Hyperkalemia is a potentially life-threatening condition that may affect as many as 10% of hospitalized patients. In this interview George Bakris, MD discusses the pathophysiology and the mechanisms of action for therapies to correct this condition.
Upon completion of the educational activity, participants should be able to:
Review the emerging clinical data on the pathophysiology of potassium binders.
This activity is intended for cardiologists, cardiothoracic surgeons, general internists, nurses, nurse practitioners, pharmacists and other healthcare professionals interested in improving clinical outcomes in patients with hyperkalemia.
There is no schedule for this activity.
There is no fee to register for this activity.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH, Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AKH, Inc., Advancing Knowledge in Healthcare approves this knowledge- based activity for .25 contact hour(s) (0.025 CEUs). UAN 0077-0000-16-029-H04-P. Initial Release Date: April 1, 2016.
AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded .25 Contact Hours.
AKH, Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803. This program is accredited for .25 contact hour(s) which includes 0 hour(s) of pharmacology. Program ID #21639-1.
This program was planned in accordance with AANP CE Standards and Policies and AANP.